Find Out Why Entrepreneurs in Gainesville Thrive Here
Gainesville’s thriving entrepreneurial ecosystem, supported by UF Innovate, is exemplified by the success of UF startup MYOLYN, known for its rehabilitation technology, and UF Innovate | Accelerate client Slice Engineering, a leader in 3D printing components.
Kriya Presents Data at the 2025 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
UF startup Kriya Therapeutics, Inc., presented preclinical data on its gene therapy candidate, KRIYA-825, being developed for the treatment of Geographic Atrophy.
LightPath Technologies Secures $4.9 Million Order for Infrared Cameras With an Existing Defense Customer
UF startup LightPath Technologies, Inc., announced its subsidiary G5 Infrared, a leading high-end infrared camera systems manufacturer, received a $4.9 million follow-on order from an existing defense industry customer.
NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.
UF startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with Summit Products Group, a national provider of advanced wound care solutions.
Myosin Therapeutics Awarded $3 Million NIH Grant To Advance Clinical Trial for MT-110 in Methamphetamine Use Disorder
UF Startup Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, announced that it has been awarded a $3 million grant from NIDA, part of NIH.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy designation for ATSN-201 for the treatment of X-linked retinoschisis.
LightPath Technologies Awarded Initial $2.2 Million IR Camera Order for U.S. Navy Shipboard Optics (SPEIR) Program
UF startup LightPath Technologies announced its acquired subsidiary G5 Infrared has been awarded an initial $2.2 million engineering development model (EDM) order for infrared cameras by L3Harris Technologies.
Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3–6
UF startup Rise Therapeutics announced that it will report its first clinical results from the completed dose escalation segment of its R-3750 Phase 1 clinical trial in ulcerative colitis at the upcoming DDW conference.
Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing To Further Advance Ocular Gene Therapy Programs
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing or preventing blindness, announced the successful close of an oversubscribed $150 million Series C financing round.
